AGCJ
VVUS

Alden Global Capital (Jersey)’s Vivus Inc VVUS Stock Holding History

Alden Global Capital (Jersey)’s Portfolio VVUS Stock Details VVUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-29,980
Closed -$863K – 56
2014
Q4 		$863K Buy
+29,980
New +$976K 0.21% 58

Other funds holding VVUS

NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T
Tahithromos New York $71.9M AUM 0.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Alden Global Capital (Jersey)'s VVUS Position: Q1 2015 in Review

Alden Global Capital (Jersey) sold out of Vivus Inc (VVUS) in Q1 2015, closing a stake of 29,980 shares — an estimated $863K sold.

Alden Global Capital (Jersey) first reported a position in VVUS in Q4 2014 and held it in 1 quarter. The position peaked at $863K in Q4 2014. 99 funds tracked by Wall St. Rank hold VVUS as of Q1 2015.

  • Alden Global Capital (Jersey) reported no remaining Vivus Inc position as of Q1 2015 after selling out during the quarter.
  • Alden Global Capital (Jersey) sold 29,980 Vivus Inc shares in Q1 2015, an estimated $863K.
  • Alden Global Capital (Jersey) first reported a position in Vivus Inc in Q4 2014 and held it in 1 quarter.
  • Alden Global Capital (Jersey)'s Vivus Inc position peaked at $863K in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Vivus Inc as of Q1 2015.

Based on Alden Global Capital (Jersey)'s 13F filing for Q1 2015.